Skip to main content
logo
Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
7.35
-0.14 (-1.87%)
Sep 23, 2026, 12:41 PM EDT - Market open

Gyre Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-21.225.0312.09-92.932.3
Depreciation & Amortization
3.132.521.591.111.13
Loss (Gain) From Sale of Assets
0.0200.073.340
Asset Writedown & Restructuring Costs
---83.1-
Loss (Gain) on Equity Investments
0.080.080.041.310.25
Stock-Based Compensation
9.877.160.837.2813.37
Provision & Write-off of Bad Debts
0.07-0.060.17-0.060.02
Other Operating Activities
-6.854.554.446.021.4
Change in Accounts Receivable
-1.74-10.81-5.260.29-7.92
Change in Inventory
-2.06-3.63-2.141.75-0.88
Change in Accounts Payable
-0.550.01-0.250.19-0.11
Change in Income Taxes
0.920.04-2.173-1.34
Change in Other Net Operating Assets
5.19-3.88-13.0511.492.46
Operating Cash Flow
-4.941.01-3.6425.8910.68
Operating Cash Flow Growth
---142.50%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
-1.17-1.19-2.32-8.52-4.99
Sale of Property, Plant & Equipment
0.020.030.40.66-
Cash Acquisitions
---5.46-
Divestitures
----0.57-
Sale (Purchase) of Intangibles
-1.04-0.73-0.81-0.07-0.01
Investment in Securities
5.11.42-17.16-16.74-8.82
Investing Cash Flow
2.91-0.47-19.88-19.76-13.81

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Issuance of Common Stock
0.5925.872.64--
Other Financing Activities
2.21-1.49-0.54--
Financing Cash Flow
2.824.382.12.5-

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Foreign Exchange Rate Adjustments
1.260.34-0.27-0.3-1.89
Net Cash Flow
2.0425.26-21.78.33-5.03

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-6.11-0.18-5.9617.385.69
Free Cash Flow Growth
---205.25%-
Free Cash Flow Margin
-5.56%-0.15%-5.63%15.32%5.56%
Free Cash Flow Per Share
-0.07-0.00-0.060.260.07
Levered Free Cash Flow
1.881.95-620.67-
Unlevered Free Cash Flow
1.881.95-620.67-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash Income Tax Paid
5.625.628.526.356.31
Change in Working Capital
9.96-18.26-22.8616.72-7.8
SEC Filings: 10-K · 10-Q